Spectranetics v. AIS
This article was originally published in The Gray Sheet
Executive SummarySpectranetics files countersuit in U.S. District Court in Santa Ana, California against Advanced Interventional Systems alleging trade libel, unfair competition and infringement of two patents covering its excimer laser angioplasty technology. In March, AIS had filed a suit against Spectranetics alleging infringement of four of the firm's patents ("The Gray Sheet" March 29, In Brief). AIS claims that Spectranetics' countersuit is "without merit and an attempt to divert attention" from the original suit.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.